[frame src=”https://www.drmcdougall.com/wp/wp-content/uploads/supper-surgery.jpg” width=”IMAGE_WIDTH” height=”IMAGE_HEIGHT” lightbox=”off” title=”Prostate Cancer” align=”left” ]
Due to modern medical belief in early detection with PSA testing, diagnosis of prostate cancer has increased at least 10-fold in the past 2 decades. But many doctors will tell patients that testing does more harm than good because over 90% of men diagnosed will not die from this disease. Those few who have an aggressive form are usually far beyond the reach of current therapies at the time of diagnosis. Considering the terrible side effects of surgical intervention against the small likelihood of any benefit, the McDougall Program is almost always the best option for dealing with prostate cancer.
Also see this video:
(articles open in a new window)
Wilt TJ, Brawer MK, Jones KM, et al. Radical prostatectomy versus observation for localized prostate cancer. N Engl J Med. 2012 Jul 19;367(3):203-13. http://www.ncbi.nlm.nih.gov/pubmed/22808955
Melnik BC, John SM, Carrera-Bastos P, Cordain L. The impact of cow’s milk-mediated mTORC1-signaling in the initiation and progression of prostate cancer. Nutr Metab (Lond). 2012 Aug 14; 9(1):74. http://www.biomedcentral.com/content/pdf/1743-7075-9-74.pdf
Ho E, Song Y. Zinc and prostatic cancer. Curr Opin Clin Nutr Metab Care. 2009 Nov;12(6):640-5. http://bit.ly/4alyCy
Coffey D. Similarities of prostate and breast cancer: Evolution, diet, and estrogens. Urology. 2001; 57:31-8. http://www.healthmegamall.com/Articles/BabeskinArticle228.pdf
Leitzmann MF, Stampfer MJ, Wu K, Colditz GA, Willett WC, Giovannucci EL. Zinc supplement use and risk of prostate cancer. J Natl Cancer Inst. 2003;95:1004-1007. http://jnci.oxfordjournals.org/content/95/13/1004.full.pdf
Moyad MA. Zinc for prostate disease and other conditions: a little evidence, a lot of hype, and a significant potential problem. Urol Nurs. 2004;24:49-52. http://europepmc.org/abstract/MED/15054912
Vickers AJ, Till C, Tangen CM, Lilja H, Thompson IM. An Empirical Evaluation of Guidelines on Prostate-specific Antigen Velocity in Prostate Cancer Detection. J Natl Cancer Inst. 2011 Mar 16; 103(6):462-9. http://jnci.oxfordjournals.org/content/103/6/462.full
Sakr WA . The frequency of carcinoma and intraepithelial neoplasia of the prostate in young male patients. J Urol. 1993 Aug; 150(2 Pt 1):379-85. http://cat.inist.fr/?aModele=afficheN&cpsidt=4837485
Stamey TA, Caldwell M, McNeal JE, Nolley R, Hemenez M, Downs J. The prostate specific antigen (PSA) era in the United States is over for prostate cancer: What happened in the last 20 years. J Urol. 2004 Oct;172(4, Part 1 Of 2):1297-1301. http://www.prostateawarenessfoundation.org/Stamey_J.Urol._172_2004.pdf
Fujita K, Landis P, McNeil BK, Pavlovich CP. Serial prostate biopsies are associated with an increased risk of erectile dysfunction in men with prostate cancer on active surveillance. J Urol. 2009 Dec; 182(6):2664-9. http://www.sciencedirect.com/science/article/pii/S0022534709020667
Robsahm TE, Tretli S, Dahlback A, Moan J. Vitamin D3 from sunlight may improve the prognosis of breast-, colon- and prostate cancer (Norway). Cancer Causes Control. 2004 Mar;15(2):149-58. http://www.direct-ms.org/sites/default/files/RobsahmBreastColonProstate.pdf
Thompson IM. Chemoprevention of prostate cancer: agents and study designs. J Urol. 2007 Sep;178(3 Pt 2):S9-S13. http://www.sciencedirect.com/science/article/pii/S0022534707008269